Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase I Dose Escalation Trial of Compartmental Radioimmunotherapy (cRIT) Using 177Lu-DTPA-omburtamab in Pediatric and Adolescent Patients With Recurrent or Refractory B7H3 Expressing Primary or Metastatic CNS Tumors
The purpose of this study is to find out whether 177Lu-DPTA-omburtamab is a safe treatment for children and adolescents with recurrent/refractory medulloblasto…
Recurrent MedulloblastomaRefractory MedulloblastomaCNS Metastases+1 more
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT07698899
Phase 1
A Phase 1/1b Study of IAM1363 in Participants With Advanced Cancers Harboring HER2 Alterations
This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 i…
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Estimated
~$10 – $8,750
Iambic Therapeutics, IncNCT06253871